Expanded Access to NanoDoce

NanOlogy

Status

Conditions: Urogenital Neoplasms

Treatments: Drug: NanoDoce (sterile nanoparticulate docetaxel) Powder for Suspension

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT04060628

NANODOCE-EA

Details and patient eligibility

About

NanOlogy may consider offering expanded access to NanoDoce for patients who do not meet the enrollment criteria of clinical trials in progress.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

-

Exclusion criteria

-